148 related articles for article (PubMed ID: 37918946)
21. No evidence for mutations in NLRP7 and KHDC3L in women with androgenetic hydatidiform moles.
Mahadevan S; Wen S; Balasa A; Fruhman G; Mateus J; Wagner A; Al-Hussaini T; Van den Veyver IB
Prenat Diagn; 2013 Dec; 33(13):1242-7. PubMed ID: 24105752
[TBL] [Abstract][Full Text] [Related]
22. Recurrent familial hydatidiform mole - a rare clinical problem.
Rai L; Shripad H; Guruvayare S; Prashant A; Sunil A
J Turk Ger Gynecol Assoc; 2012; 13(4):284-6. PubMed ID: 24592059
[TBL] [Abstract][Full Text] [Related]
23. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
[TBL] [Abstract][Full Text] [Related]
24. Recurrent hydatidiform mole: detection of two novel mutations in the NLRP7 gene in two Egyptian families.
Abdalla EM; Hayward BE; Shamseddin A; Nawar MM
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):211-5. PubMed ID: 22770628
[TBL] [Abstract][Full Text] [Related]
25. Detection of Parental Contribution to Molar Genome Leads to Diagnosis of Recurrent Hydatidiform Mole in a Family with
Wang RY; Li YJ; Zhen L; Jiang F; Gu CM; Li DZ
Fetal Pediatr Pathol; 2022 Jun; 41(3):511-515. PubMed ID: 33252287
[No Abstract] [Full Text] [Related]
26. Recurrent pregnancy loss due to familial and non-familial habitual molar pregnancy.
Al-Hussaini TK; Abd el-Aal DM; Van den Veyver IB
Int J Gynaecol Obstet; 2003 Nov; 83(2):179-86. PubMed ID: 14550593
[TBL] [Abstract][Full Text] [Related]
27. Recurrent hydatidiform moles.
Williams D; Hodgetts V; Gupta J
Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):3-7. PubMed ID: 20171777
[TBL] [Abstract][Full Text] [Related]
28. NLRP7 mutation analysis in sporadic hydatidiform moles in Tunisian patients: NLRP7 and sporadic mole.
Landolsi H; Rittore C; Philibert L; Hmissa S; Gribaa M; Touitou I; Yacoubi MT
Arch Pathol Lab Med; 2012 Jun; 136(6):646-51. PubMed ID: 22646272
[TBL] [Abstract][Full Text] [Related]
29. The spectrum of NLRP7 mutations in French patients with recurrent hydatidiform mole.
Muhlstein J; Golfier F; Rittore C; Hajri T; Philibert L; Abel F; Beneteau C; Touitou I
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):197-9. PubMed ID: 21439709
[TBL] [Abstract][Full Text] [Related]
30. Gestational trophoblastic disease.
Garner EI; Goldstein DP; Feltmate CM; Berkowitz RS
Clin Obstet Gynecol; 2007 Mar; 50(1):112-22. PubMed ID: 17304028
[TBL] [Abstract][Full Text] [Related]
31. Absence of KHDC3L mutations in Chinese patients with recurrent and sporadic hydatidiform moles.
Zhao W; Muhetaer A; Luo T; Zhou W; Qi C; Chen X; Zhang X; Zhang Z; Dery C; Slim R; Qian J
Cancer Genet; 2013; 206(9-10):327-9. PubMed ID: 24215781
[TBL] [Abstract][Full Text] [Related]
32. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
33. [Review: Repetitive hydatidiform moles].
Muhlstein J; Golfier F; Frappart L; Poulizac G; Abel F; Touitou I; Hajri T; Raudrant D
Gynecol Obstet Fertil; 2010 Nov; 38(11):672-6. PubMed ID: 20965770
[TBL] [Abstract][Full Text] [Related]
34. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
[TBL] [Abstract][Full Text] [Related]
35. Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease.
Zheng XZ; Qin XY; Chen SW; Wang P; Zhan Y; Zhong PP; Buza N; Jin YL; Wu BQ; Hui P
Mod Pathol; 2020 Oct; 33(10):1979-1988. PubMed ID: 32404958
[TBL] [Abstract][Full Text] [Related]
36. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
37. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
38. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
[TBL] [Abstract][Full Text] [Related]
39. Screening for NLRP7 mutations in familial and sporadic recurrent hydatidiform moles: report of 2 Tunisian families.
Landolsi H; Rittore C; Philibert L; Missaoui N; Hmissa S; Touitou I; Gribaa M; Yacoubi MT
Int J Gynecol Pathol; 2011 Jul; 30(4):348-53. PubMed ID: 21623199
[TBL] [Abstract][Full Text] [Related]
40. [Use of sulprostone in the evacuation of molar pregnancies].
Pinet C; Colau JC
Rev Fr Gynecol Obstet; 1991 Jan; 86(1):53-5. PubMed ID: 2068488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
